Eli Lilly's Obesity Drug Amylin Shows Up to 20% Weight Loss in Study
The Eli Lilly Biotechnology Center is shown in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli…
Roche Holding AG
Genentech Launches Direct-to-Consumer Program for Flu Pill Xofluza
A sign stands in front of a Genentech office on June 12, 2025 in south San Francisco, California. Justin Sullivan…
Trump The threat of the pharmaceutical rate decreases after the Pfizer agreement
The president of the United States, Donald Trump, shakes hand with the Pfizer CEO, Albert Bourla (L), while announcing an…
Roche plans to become the best obesity player as CT-388 enters trial
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty…
How LPG-1s, Wogovy, Zepbound are restructuring the economy
Eternalcreative | Istock | Getty images Miraculous drugs, obesity treatments and skinny blows. They call them what they want, few…
Trump administration to pilot that covers obesity drugs
A combined image shows a Zepbound injection pen, the Wogovy Eli Lilly weight loss drug and Wogovy boxes, made by…
Novartis, Roche could be at greater risk
The medications are stored on shelves on a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer |…
Medicaid's cuts in Trump's Megabill will hit some drug manufacturers
The president of the United States, Donald Trump, presents a broad legislation of expenses and prosecutors, known as the “Law…
Trump's pharmaceutical rates feed new investments in the United States
JGI/Jamie Grill | Tetra images | Getty images A version of this article appeared for the first time in the…
Eli Lilly Orforglipron weight loss pill erases the first late stage test
Eli Lilly On Thursday, its daily obesity pill met the company's objectives in the first of several tests in the…